Once a year the Biotechnology Business Institute brings together experts in lifesciences and young scietific profesional. The event is focus in healthcare and how the industry model is evolving due to the external R&D acquisition of biotech companies with and so as well, how scientific profiles are becoming more important to manage this projects our sector.
Divided in conferences and open discussions this seminars allow the audience to interact with leading profesionals developing their career from a global perspective and so stablish debates due to last trends in the sector.
The importance of scientific profiles in a society based in innovation and how their profesional development in management can contribute to drug discovery, were some of the main topics of the seminars that the Biotechnology Business Institute presented during the BBI Opend day 2019
In May, the Biotechnology Business Institute organized the first BBI Open Day at the Barcelona Scietific Park with the main pourpose of increase the awarness of the importance of scientific managers in the biotechnology sector and the pharmaceutical industry with focus in drug discovery in an evolving society towards innovation as one of the main key factor for a sustainable support to the economy.
Speakers in 2019 edition
Juan R. Garcia Chairman at the Biotechnology Business Institute
Iolanda Marchueta Global Project Leader & Customer Account Manager at AstraZeneca
Albert Barberà Managing Director of Innovation at Catalan Government
Ernest Mas Director of Marketing EMA for Diagnostics Grifolls
Mireia Angulo Investment Analyst at Caixa Capital Risk
Nerea Blanqué Market Market Access & Prceing Director at Ferrer